skin prick testing in patients using beta-blockers a retrospective analysis皮肤刺痛测试使用β受体阻断剂的患者进行回顾性分析.pdfVIP

Fung and Kim Allergy, Asthma Clinical Immunology 2010, 6:2 /content/6/1/2 ALLERGY, ASTHMA CLINICAL IMMUNOLOGY RESEARCH Open Access Skin prick testing in patients using beta-blockers: a retrospective analysis 1 1,2* Irene N Fung , Harold L Kim Abstract Rationale: The use of beta-blockers is a relative contraindication in allergen skin testing yet there is a paucity of literature on adverse events in this circumstance. We examined a population of skin tested patients on beta- blockers to look for any adverse effects. Methods: Charts from 2004-2008 in a single allergy clinic were reviewed for any patients taking a beta-blocker when skin tested. Data was examined for skin test reactivity, type of skin test, concomitant asthma diagnosis, allergens tested, and adverse events. Results: One hundred and ninety-one patients were taking beta-blockers when skin testing occurred. Seventy-two patients had positive skin tests. No tests resulted in an adverse event. Conclusions: This data demonstrates the relative safety of administrating of skin prick tests to patients on beta- blocker treatment. Larger prospective studies are needed to substantiate the findings of this study. Introduction for IgE-mediated disease cannot stop treatment with a Beta antagonists, commonly known as beta-blockers, are beta-blocking agent [12].” However, in our literature a commonly prescribed class of medications. Beta-block- review on the topic, no case reports or prospective stu- ers are used in the treatment of congestive heart failure,